熱門資訊> 正文
EyePoint文件自动混合证券货架
2025-10-15 04:27
- EyePoint Pharmaceuticals (NASDAQ:EYPT) filed automatic mixed securities shelf.
- Filing
More on EyePoint Pharmaceuticals
- EyePoint Pharmaceuticals, Inc. (EYPT) Presents At Citi's Biopharma Back To School Conference Transcript
- EyePoint signals 2026 LUGANO Phase III data and NDA filing for DURAVYU amid accelerated trial enrollment
- EyePoint Pharmaceuticals GAAP EPS of -$0.85 misses by $0.04, revenue of $5.3M misses by $0.86M
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。